Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia.

Lai J, Syngelaki A, Poon LC, Nucci M, Nicolaides KH.

Fetal Diagn Ther. 2013;33(3):149-55. doi: 10.1159/000343220. Epub 2012 Nov 13.

PMID:
23154616
[PubMed - indexed for MEDLINE]
Free Article
2.

Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.

Lai J, Pinas A, Syngelaki A, Poon LC, Nicolaides KH.

J Matern Fetal Neonatal Med. 2013 May;26(8):733-7. doi: 10.3109/14767058.2012.755167. Epub 2013 Jan 10.

PMID:
23205865
[PubMed - indexed for MEDLINE]
3.

Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia.

Mosimann B, Wagner M, Birdir C, Poon LC, Nicolaides KH.

J Matern Fetal Neonatal Med. 2013 May;26(8):763-7. doi: 10.3109/14767058.2012.755168. Epub 2013 Mar 25.

PMID:
23205868
[PubMed - indexed for MEDLINE]
4.

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E, Dong Z, Tarca A, Gaurav B, Hassan SS.

J Matern Fetal Neonatal Med. 2011 Oct;24(10):1187-207. doi: 10.3109/14767058.2011.589932. Epub 2011 Aug 9.

PMID:
21827221
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.

Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH.

Ultrasound Obstet Gynecol. 2008 Nov;32(6):732-9. doi: 10.1002/uog.6244. Erratum in: Ultrasound Obstet Gynecol. 2009 Feb;33(2):249.

PMID:
18956425
[PubMed - indexed for MEDLINE]
Free Article
6.

Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, Dong Z, Than NG, Yeo L, Hernandez-Andrade E, Conde-Agudelo A, Hassan SS.

Am J Obstet Gynecol. 2013 Apr;208(4):287.e1-287.e15. doi: 10.1016/j.ajog.2013.01.016. Epub 2013 Jan 17.

PMID:
23333542
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia.

Lai J, Pinas A, Poon LC, Agathokleous M, Nicolaides KH.

Fetal Diagn Ther. 2013;33(3):164-72. doi: 10.1159/000345090. Epub 2013 Feb 20.

PMID:
23445908
[PubMed - indexed for MEDLINE]
8.

Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.

Hirashima C, Ohkuchi A, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M.

Hypertens Res. 2008 Aug;31(8):1541-8. doi: 10.1291/hypres.31.1541.

PMID:
18971528
[PubMed - indexed for MEDLINE]
9.

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R.

Hypertension. 2007 Jul;50(1):137-42. Epub 2007 May 21.

PMID:
17515455
[PubMed - indexed for MEDLINE]
Free Article
10.

Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?

Myatt L, Clifton RG, Roberts JM, Spong CY, Wapner RJ, Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Sciscione A, Tolosa JE, Saade G, Sorokin Y, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

BJOG. 2013 Sep;120(10):1183-91. doi: 10.1111/1471-0528.12128. Epub 2013 Jan 18.

PMID:
23331974
[PubMed - indexed for MEDLINE]
11.

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS.

J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.

PMID:
19900040
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.

Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV.

Am J Obstet Gynecol. 2008 Sep;199(3):266.e1-6. doi: 10.1016/j.ajog.2008.06.069.

PMID:
18771978
[PubMed - indexed for MEDLINE]
13.

Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.

Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH.

Prenat Diagn. 2009 Dec;29(12):1103-8. doi: 10.1002/pd.2375.

PMID:
19777530
[PubMed - indexed for MEDLINE]
14.

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Than NG, Gomez R, Hassan SS.

J Matern Fetal Neonatal Med. 2008 May;21(5):279-87. doi: 10.1080/14767050802034545.

PMID:
18446652
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia.

Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH.

Ultrasound Obstet Gynecol. 2009 Feb;33(2):135-41. doi: 10.1002/uog.6275.

PMID:
19173240
[PubMed - indexed for MEDLINE]
Free Article
16.

Circulating soluble endoglin and placental abruption.

Signore C, Mills JL, Qian C, Yu KF, Rana S, Karumanchi SA, Levine RJ.

Prenat Diagn. 2008 Sep;28(9):852-8. doi: 10.1002/pd.2065.

PMID:
18702104
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.

Foidart JM, Munaut C, Chantraine F, Akolekar R, Nicolaides KH.

Ultrasound Obstet Gynecol. 2010 Jun;35(6):680-7. doi: 10.1002/uog.7621.

PMID:
20205159
[PubMed - indexed for MEDLINE]
Free Article
18.

Soluble endoglin for the prediction of preeclampsia in a high risk cohort.

Maynard SE, Moore Simas TA, Bur L, Crawford SL, Solitro MJ, Meyer BA.

Hypertens Pregnancy. 2010;29(3):330-41. doi: 10.3109/10641950902968684.

PMID:
20670156
[PubMed - indexed for MEDLINE]
19.

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.

Stepan H, Geipel A, Schwarz F, Krämer T, Wessel N, Faber R.

Am J Obstet Gynecol. 2008 Feb;198(2):175.e1-6. doi: 10.1016/j.ajog.2007.08.052.

PMID:
18226617
[PubMed - indexed for MEDLINE]
20.

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.

Rana S, Cerdeira AS, Wenger J, Salahuddin S, Lim KH, Ralston SJ, Thadhani RI, Karumanchi SA.

PLoS One. 2012;7(10):e48259. doi: 10.1371/journal.pone.0048259. Epub 2012 Oct 26.

PMID:
23110221
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk